IL-17 mediates articular hypernociception in antigen-induced arthritis in mice-Reference-Cited by-同舟云学术

IL-17 mediates articular hypernociception in antigen-induced arthritis in mice

Published:2010-02 Issue:2 Volume:148 Page:247-256
ISSN:0304-3959
Container-title:Pain
language:en
Short-container-title:

Author:

Pinto Larissa G.,Cunha Thiago M.,Vieira Silvio M.,Lemos Henrique P.,Verri Waldiceu A.,Cunha Fernando Q.,Ferreira Sergio H.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Anesthesiology and Pain Medicine,Clinical Neurology,Neurology

Reference70 articles.

1. IL-17 is produced by nickel-specific T lymphocytes and regulates ICAM-1 expression and chemokine production in human keratinocytes: synergistic or antagonist effects with IFN-gamma and TNF-alpha.;Albanesi;J Immunol,1999

2. Interleukin-1-induced prostaglandin E2 biosynthesis in human synovial cells involves the activation of cytosolic phospholipase A2 and cyclooxygenase-2.;Angel;Eur J Biochem,1994

3. Inhibition of the production and effects of interleukin-1 and tumor necrosis factor alpha in rheumatoid arthritis.;Arend;Arthritis Rheum,1995

4. The pathophysiology and treatment of rheumatoid arthritis.;Arend;Arthritis Rheum,1997

5. Neutrophils-derived peroxynitrite contributes to acute hyperalgesia and cell influx in zymosan arthritis.;Bezerra;Naunyn Schmiedebergs Arch Pharmacol,2007

Cited by 148 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunomodulation and fibroblast dynamics driving nociceptive joint pain within inflammatory synovium: Unravelling mechanisms for therapeutic advancements in osteoarthritis;Osteoarthritis and Cartilage;2024-07

2. Fucoidan as a Promising Drug for Pain Treatment: Systematic Review and Meta-Analysis;Marine Drugs;2024-06-24

3. Immune drivers of physiological and pathological pain;Journal of Experimental Medicine;2024-04-12

4. Resveratrol Attenuates Rheumatoid Arthritis Induce Neutrophil Extracellular Traps via TLR-4 Mediated Inflammation in C57BL/6 Mice;Physiological Research;2024-03-06

5. Interleukin-17: A Putative Novel Pharmacological Target for Pathological Pain;Current Neuropharmacology;2024-02